Physician profile
Steven L Brown
NPI 1982714150
$1,187.67
in general payments reported to CMS, 2019-2025
11 companies · $17.75 in 2025
The $17.75 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $14.94 · 2021: $125 · 2023: $557 · 2024: $258 · 2025: $17.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $333.10 | 2023-2024 | Watchman Access System |
| Abiomed | $216.16 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $145.02 | 2019-2023 | |
| Pfizer INC. | $120.59 | 2024 | |
| Janssen Pharmaceuticals, INC | $119.97 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $110.28 | 2019-2023 | Camzyos |
| Cvrx, INC. | $82.03 | 2019 | |
| Novo Nordisk INC | $17.75 | 2025 | |
| Merck Sharp & Dohme LLC | $15.21 | 2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $14.94 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.